Publications by authors named "Gordon Dewald"

Claim this Profile
M
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Elisabeth Paietta, Kathryn G Roberts, Victoria Wang, Zhaohui Gu, Georgina A N Buck, Gordon W Dewald

Blood· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900.
Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, Selina M Luger, Elisabeth Paietta, Gordon W Dewald

Haematologica· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials.
Stephen A Strickland, Zhuoxin Sun, Rhett P Ketterling, Athena M Cherry, Larry D Cripe, Gordon Dewald

Leuk Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.
David M Lucas, Amy S Ruppert, Gerard Lozanski, Gordon W Dewald, Arletta Lozanski

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial.
David I Marks, Anthony V Moorman, Lucy Chilton, Elisabeth Paietta, Amir Enshaie, Gordon DeWald

Haematologica· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17).
Peter H Wiernik, Zhuoxin Sun, Holly Gundacker, Gordon Dewald, Marilyn L Slovak

Med Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
Athena M Cherry, Marilyn L Slovak, Lynda J Campbell, Kathy Chun, Virginie Eclache, Gordon W Dewald

Leuk Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.
Mitchell R Smith, Donna Neuberg, Ian W Flinn, Michael R Grever, Hillard M Lazarus, Gordon Dewald

Blood· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin.
Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, Selina M Luger, Elisabeth M Paietta, Gordon Dewald

Blood· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium.
Stephanie A Smoley, Daniel L Van Dyke, Neil E Kay, Nyla A Heerema, Marie L Dell' Aquila, Gordon W Dewald

Cancer Genet Cytogenet· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group.
Mark R Litzow, Megan Othus, Larry D Cripe, Steven D Gore, Hillard M Lazarus, Gordon W Dewald

Br J Haematol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
David I Marks, Elisabeth M Paietta, Anthony V Moorman, Susan M Richards, Georgina Buck, Gordon DeWald

Blood· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).
Peter L Greenberg, Zhuoxin Sun, Kenneth B Miller, John M Bennett, Martin S Tallman, Gordon Dewald

Blood· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.
Gordon W Dewald, Thomas C Smyrk, Erik C Thorland, Robert R McWilliams, Daniel L Van Dyke

Mayo Clin Proc· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthracycline dose intensification in acute myeloid leukemia.
Hugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, Mark R Litzow, Selina M Luger, Gordon W Dewald

N Engl J Med· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide.
Sheng Wei, Xianghong Chen, Kathy Rocha, P K Epling-Burnette, Julie Y Djeu, Gordon Dewald

Proc Natl Acad Sci U S A· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Adele K Fielding, Jacob M Rowe, Susan M Richards, Georgina Buck, Anthony V Moorman, Gordon Dewald

Blood· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.
Grzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, Clive S Zent, Timothy G Call, Gordon W Dewald

J Clin Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.
Rafael Santana-Davila, Ayalew Tefferi, Shernan G Holtan, Rhett P Ketterling, Gordon W Dewald

Leuk Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood cytogenetic studies in myelofibrosis: overall yield and comparison with bone marrow cytogenetic studies.
Kebede Hussein, Rhett P Ketterling, Gordon W Dewald, Daniel L Van Dyke, Ruben Mesa

Leuk Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Working Group on MDS cytogenetics: October 2007 meeting report.
Marilyn L Slovak, Gordon W Dewald,

Leuk Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Shernan G Holtan, Rafael Santana-Davila, Gordon W Dewald, Rhett P Khetterling, Ryan A Knudson

Am J Hematol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression.
Tait D Shanafelt, Curtis Hanson, Gordon W Dewald, Thomas E Witzig, Betsy LaPlant

J Clin Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence.
John L Frater, Neil E Kay, Charles L Goolsby, Susan E Crawford, Gordon W Dewald

Diagn Pathol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
Tait D Shanafelt, Susan M Geyer, Nancy D Bone, Renee C Tschumper, Tom E Witzig, Gordon W Dewald

Br J Haematol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis